Group 1 - The core viewpoint of the articles highlights the financial performance and market position of Yingke Medical, which has a current PE ratio of 9.43, significantly lower than the industry average of 51.00 [1][2] - As of March 31, 2025, Yingke Medical has 61,786 shareholders, an increase of 1,641 from the previous period, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares [1] - The company specializes in the research, production, and sales of high-performance personal protective products, including disposable nitrile gloves, PVC gloves, isolation gowns, masks, and various medical equipment [1] Group 2 - In the first quarter of 2025, Yingke Medical reported a revenue of 2.494 billion yuan, representing a year-on-year increase of 13.20%, and a net profit of 353 million yuan, up 48.08%, with a gross profit margin of 24.16% [1] - The company's total market capitalization is 14.895 billion yuan, ranking it 31st in the medical device industry based on PE ratio [1][2] - The industry median PE ratio is 37.03, indicating that Yingke Medical is trading at a significant discount compared to its peers [2]
英科医疗收盘下跌1.28%,滚动市盈率9.43倍,总市值148.95亿元